“MHC Class I-Presented Tumor Antigen Appraisable for T-Cell Responses Against Ovarian Cancer”. 2015. Bangladesh Journal of Pharmacology 10 (3): 524-28. https://doi.org/10.3329/bjp.v10i3.23076.